Hainan Haiyao: Announcement on Change of Sponsor Representative
Hainan Haiyao: Announcement on cooperation between the company and New Zealand AFT Pharmaceuticals Ltd on exclusive commercialization rights for related products
Hainan Haiyao: Announcement on Signing an Enforcement Settlement Agreement
Hainan Haiyao: Announcement on Adding Provisional Proposals for the 2024 Third Extraordinary General Meeting of Shareholders and Supplementary Notice of Convening the 2024 Third Extraordinary General Meeting of Shareholders
Hainan Haiyao: Notice on Convening the Third Extraordinary General Meeting of Shareholders in 2024
Hainan Haiyao: Progress Notice on the Formal Signing of the Initial Joint Venture Contract
Hainan Haiyao: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Hainan Haiyao: Legal Opinion on the 2024 Second Extraordinary General Meeting of Shareholders of Hainan Haiyao Co., Ltd.
Hainan Haiyao: Announcement on Signing the Initial Joint Venture Contract
Hainan Haiyao: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Hainan Haiyao: Notice on the progress of the lawsuit
Hainan Haiyao: Announcement on the holding subsidiary obtaining a notice of approval for the marketing application of linezolid chemical raw materials
Hainan Haiyao: Notice on Abnormal Stock Trading Fluctuations and Risk Alerts
Hainan Haiyao: Notice on Abnormal Stock Trading Fluctuations and Risk Alerts
Hainan Haiyao: Announcement on the Disposal of Idle Assets by Jiangsu Pujian Pharmaceutical Co., Ltd.
Hainan Haiyao: Announcement on the impact of the typhoon
Hainan Haiyao: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Hainan Haiyao: 2024 Semi-Annual Financial Report
Hainan Haiyao: Announcement on the Mid-term Analysis Results of Phase II Clinical Trial of Fluorfenilone Capsules
Hainan Haiyao: Announcement regarding the resignation of Vice Chairman.